Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Kappac Pharma Ltd is 'Not Rated'. Macroaxis provides Kappac Pharma buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding KAPPH positions. The advice algorithm takes into account all of Kappac Pharma available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from KAPPH buy-and-hold prospective. Please see also Stocks Correlation.
For the selected time horizon Kappac Pharma Ltd has a risk adjusted performance of 0.0, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.0 and treynor ratio of 0.0Macroaxis provides buy or sell recommendations on Kappac Pharma to complement and cross-verify current analyst consensus on Kappac Pharma. Our advice engine determines the firm potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. Use Kappac Pharma Ltd Cash and Equivalents, Book Value Per Share as well as the relationship between Book Value Per Share and Total Asset to make sure your buy or sell decision on Kappac Pharma is adequate.
Kappac Pharma Trading Alerts and Improvement Suggestions
|Kappac Pharma is not yet fully synchronised with the market data|
|The company reported revenue of . Net Loss for the year was (786K).|